{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:20:16Z","timestamp":1790968816770,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T00:00:00Z","timestamp":1298592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transgenic Res"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s11248-011-9496-8","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T13:56:42Z","timestamp":1298555802000},"page":"1293-1304","source":"Crossref","is-referenced-by-count":42,"title":["Disruption of the Survival Motor Neuron (SMN) gene in pigs using ssDNA"],"prefix":"10.1007","volume":"20","author":[{"given":"Monique A.","family":"Lorson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee D.","family":"Spate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa S.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton N.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall S.","family":"Prather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,25]]},"reference":[{"key":"9496_CR1","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/hmg\/10.24.2841","volume":"10","author":"C Andreassi","year":"2001","unstructured":"Andreassi C, Jarecki J, Zhou J, Coovert DD, Monani UR, Chen X, Whitney M, Pollok B, Zhang M, Androphy E et al (2001) Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 10:2841\u20132849","journal-title":"Hum Mol Genet"},{"key":"9496_CR2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","volume":"12","author":"C Andreassi","year":"2004","unstructured":"Andreassi C, Angelozzi C, Tiziano FD, Vitali T, De Vincenzi E, Boninsegna A, Villanova M, Bertini E, Pini A, Neri G et al (2004) Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet 12:59\u201365","journal-title":"Eur J Hum Genet"},{"key":"9496_CR3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymthe.2006.01.012","volume":"14","author":"T Baughan","year":"2006","unstructured":"Baughan T, Shababi M, Coady TH, Dickson AM, Tullis GE, Lorson CL (2006) Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector. Mol Ther 14:54\u201362","journal-title":"Mol Ther"},{"key":"9496_CR4","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/hmg\/ddp076","volume":"18","author":"TD Baughan","year":"2009","unstructured":"Baughan TD, Dickson A, Osman EY, Lorson CL (2009) Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy. Hum Mol Genet 18:1600\u20131611","journal-title":"Hum Mol Genet"},{"key":"9496_CR5","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","volume":"12","author":"L Brichta","year":"2003","unstructured":"Brichta L, Hofmann Y, Hahnen E, Siebzehnrubl FA, Raschke H, Blumcke I, Eyupoglu IY, Wirth B (2003) Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 12:2481\u20132489","journal-title":"Hum Mol Genet"},{"key":"9496_CR6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/hmg\/ddp510","volume":"19","author":"ME Butchbach","year":"2010","unstructured":"Butchbach ME, Singh J, Thorsteinsdottir M, Saieva L, Slominski E, Thurmond J, Andresson T, Zhang J, Edwards JD, Simard LR et al (2010) Effects of 2, 4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy. Hum Mol Genet 19:454\u2013467","journal-title":"Hum Mol Genet"},{"key":"9496_CR7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Krainer AR (2002) Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30:377\u2013384","journal-title":"Nat Genet"},{"key":"9496_CR8","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"JG Chang","year":"2001","unstructured":"Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 98:9808\u20139813","journal-title":"Proc Natl Acad Sci USA"},{"key":"9496_CR9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1523\/JNEUROSCI.4489-09.2010","volume":"30","author":"TH Coady","year":"2010","unstructured":"Coady TH, Lorson CL (2010) Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy. J Neurosci 30:126\u2013130","journal-title":"J Neurosci"},{"key":"9496_CR10","doi-asserted-by":"crossref","first-page":"e3468","DOI":"10.1371\/journal.pone.0003468","volume":"3","author":"TH Coady","year":"2008","unstructured":"Coady TH, Baughan TD, Shababi M, Passini MA, Lorson CL (2008) Development of a single vector system that enhances trans-splicing of SMN2 transcripts. PLoS One 3:e3468","journal-title":"PLoS One"},{"key":"9496_CR11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nbt0302-251","volume":"20","author":"Y Dai","year":"2002","unstructured":"Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S, Monahan JA, Jobst PM, McCreath KJ, Lamborn AE et al (2002) Targeted disruption of the alpha 1, 3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 20:251\u2013255","journal-title":"Nat Biotechnol"},{"key":"9496_CR12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","volume":"20","author":"E Dominguez","year":"2011","unstructured":"Dominguez E, Marais T, Chatauret N, Benkhelifa-Ziyyat S, Duque S, Ravassard P, Carcenac R, Astord S, de Moura AP, Voit T, Barkats M (2011) Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet 20:681\u2013693","journal-title":"Hum Mol Genet"},{"key":"9496_CR13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mus.21350","volume":"40","author":"B Elsheikh","year":"2009","unstructured":"Elsheikh B, Prior T, Zhang X, Miller R, Kolb SJ, Moore D, Bradley W, Barohn R, Bryan W, Gelinas D et al (2009) An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy. Muscle Nerve 40:652\u2013656","journal-title":"Muscle Nerve"},{"key":"9496_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM, Le TT, Morales PR, Rich MM, Burghes AH et al (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol 28:271\u2013274","journal-title":"Nat Biotechnol"},{"key":"9496_CR15","doi-asserted-by":"crossref","first-page":"e8204","DOI":"10.1371\/journal.pone.0008204","volume":"4","author":"T Geib","year":"2009","unstructured":"Geib T, Hertel KJ (2009) Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs. PLoS One 4:e8204","journal-title":"PLoS One"},{"key":"9496_CR16","doi-asserted-by":"crossref","first-page":"5ra12","DOI":"10.1126\/scitranslmed.3000208","volume":"1","author":"ML Hastings","year":"2009","unstructured":"Hastings ML, Berniac J, Liu YH, Abato P, Jodelka FM, Barthel L, Kumar S, Dudley C, Nelson M, Larson K et al (2009) Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy. Sci Transl Med 1:5ra12","journal-title":"Sci Transl Med"},{"key":"9496_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","volume":"24","author":"HM Hsieh-Li","year":"2000","unstructured":"Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, Tsai CH, Li H (2000) A mouse model for spinal muscular atrophy. Nat Genet 24:66\u201370","journal-title":"Nat Genet"},{"key":"9496_CR51","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"Y Hua","year":"2008","unstructured":"Hua Y, Vickers T, Okunola H, Bennett C, Krainer, A (2008) Antisense masking of an hnRNP A1\/A2 intronic splice silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet 82:834\u2013848","journal-title":"Am J Hum Genet"},{"key":"9496_CR50","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","volume":"24","author":"Y Hua","year":"2010","unstructured":"Hua Y, Sahaski K, Hung G, Rigo F, Passini M, Bennett C, Krainer A (2010) Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev 24:1634\u20131644","journal-title":"Genes Dev"},{"key":"9496_CR18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1477-7827-1-82","volume":"1","author":"L Lai","year":"2003","unstructured":"Lai L, Prather RS (2003) Creating genetically modified pigs by using nuclear transfer. Reprod Biol Endocrinol 1:82","journal-title":"Reprod Biol Endocrinol"},{"key":"9496_CR19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1068228","volume":"295","author":"L Lai","year":"2002","unstructured":"Lai L, Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, Im GS, Samuel M, Bonk A, Rieke A, Day BN et al (2002) Production of alpha-1, 3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295:1089\u20131092","journal-title":"Science"},{"key":"9496_CR20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","volume":"14","author":"TT Le","year":"2005","unstructured":"Le TT, Pham LT, Butchbach ME, Zhang HL, Monani UR, Coovert DD, Gavrilina TO, Xing L, Bassell GJ, Burghes AH (2005) SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 14:845\u2013857","journal-title":"Hum Mol Genet"},{"key":"9496_CR21","doi-asserted-by":"crossref","first-page":"45476","DOI":"10.1074\/jbc.M107632200","volume":"276","author":"SR Lim","year":"2001","unstructured":"Lim SR, Hertel KJ (2001) Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3\u2032 splice site pairing. J Biol Chem 276:45476\u201345483","journal-title":"J Biol Chem"},{"key":"9496_CR22","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 96:6307\u20136311","journal-title":"Proc Natl Acad Sci USA"},{"key":"9496_CR23","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/dvdy.21642","volume":"237","author":"MA Lorson","year":"2008","unstructured":"Lorson MA, Spate LD, Prather RS, Lorson CL (2008) Identification and characterization of the porcine (Sus scrofa) survival motor neuron (SMN1) gene: an animal model for therapeutic studies. Dev Dyn 237:2268\u20132278","journal-title":"Dev Dyn"},{"key":"9496_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/hmg\/ddq147","volume":"19","author":"CL Lorson","year":"2010","unstructured":"Lorson CL, Rindt H, Shababi M (2010) Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet 19:111\u2013118","journal-title":"Hum Mol Genet"},{"key":"9496_CR25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1095\/biolreprod57.5.1123","volume":"57","author":"Z Machaty","year":"1997","unstructured":"Machaty Z, Wang WH, Day BN, Prather RS (1997) Complete activation of porcine oocytes induced by the sulfhydryl reagent, thimerosal. Biol Reprod 57:1123\u20131127","journal-title":"Biol Reprod"},{"key":"9496_CR26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nbt0310-235","volume":"28","author":"A MacKenzie","year":"2010","unstructured":"MacKenzie A (2010) Genetic therapy for spinal muscular atrophy. Nat Biotechnol 28:235\u2013237","journal-title":"Nat Biotechnol"},{"key":"9496_CR27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ymthe.2005.08.022","volume":"12","author":"C Madocsai","year":"2005","unstructured":"Madocsai C, Lim SR, Geib T, Lam BJ, Hertel KJ (2005) Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs. Mol Ther 12:1013\u20131022","journal-title":"Mol Ther"},{"key":"9496_CR28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00439-006-0245-7","volume":"120","author":"VB Mattis","year":"2006","unstructured":"Mattis VB, Rai R, Wang J, Chang CW, Coady T, Lorson CL (2006) Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts. Hum Genet 120:589\u2013601","journal-title":"Hum Genet"},{"key":"9496_CR29","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddp333","volume":"18","author":"VB Mattis","year":"2009","unstructured":"Mattis VB, Ebert AD, Fosso MY, Chang CW, Lorson CL (2009a) Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model. Hum Mol Genet 18:3906\u20133913","journal-title":"Hum Mol Genet"},{"key":"9496_CR30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2202-10-142","volume":"10","author":"VB Mattis","year":"2009","unstructured":"Mattis VB, Fosso MY, Chang CW, Lorson CL (2009b) Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA. BMC Neurosci 10:142","journal-title":"BMC Neurosci"},{"key":"9496_CR31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nbd.2010.01.006","volume":"38","author":"M Michaud","year":"2010","unstructured":"Michaud M, Arnoux T, Bielli S, Durand E, Rotrou Y, Jablonka S, Robert F, Giraudon-Paoli M, Riessland M, Mattei MG et al (2010) Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy. Neurobiol Dis 38:125\u2013135","journal-title":"Neurobiol Dis"},{"key":"9496_CR32","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, McPherson JD (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8:1177\u20131183","journal-title":"Hum Mol Genet"},{"key":"9496_CR33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","volume":"9","author":"UR Monani","year":"2000","unstructured":"Monani UR, Sendtner M, Coovert DD, Parsons DW, Andreassi C, Le TT, Jablonka S, Schrank B, Rossol W, Prior TW et al (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(\u2212\/\u2212) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 9:333\u2013339","journal-title":"Hum Mol Genet"},{"key":"9496_CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200208079","volume":"160","author":"UR Monani","year":"2003","unstructured":"Monani UR, Pastore MT, Gavrilina TO, Jablonka S, Le TT, Andreassi C, DiCocco JM, Lorson C, Androphy EJ, Sendtner M et al (2003) A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy. J Cell Biol 160:41\u201352","journal-title":"J Cell Biol"},{"key":"9496_CR35","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","volume":"120","author":"MA Passini","year":"2010","unstructured":"Passini MA, Bu J, Roskelley EM, Richards AM, Sardi SP, O\u2019Riordan CR, Klinger KW, Shihabuddin LS, Cheng SH (2010) CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy. J Clin Invest 120:1253\u20131264","journal-title":"J Clin Invest"},{"key":"9496_CR36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/GIM.0b013e3181c5e713","volume":"12","author":"TW Prior","year":"2010","unstructured":"Prior TW (2010) Perspectives and diagnostic considerations in spinal muscular atrophy. Genet Med 12:145\u2013152","journal-title":"Genet Med"},{"key":"9496_CR37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","volume":"85","author":"TW Prior","year":"2009","unstructured":"Prior TW, Krainer AR, Hua Y, Swoboda KJ, Snyder PC, Bridgman SJ, Burghes AH, Kissel JT (2009) A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet 85:408\u2013413","journal-title":"Am J Hum Genet"},{"key":"9496_CR38","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/hmg\/ddq023","volume":"19","author":"M Riessland","year":"2010","unstructured":"Riessland M, Ackermann B, Forster A, Jakubik M, Hauke J, Garbes L, Fritzsche I, Mende Y, Blumcke I, Hahnen E et al (2010) SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum Mol Genet 19:1492\u20131506","journal-title":"Hum Mol Genet"},{"key":"9496_CR39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11248-009-9345-1","volume":"19","author":"JW Ross","year":"2010","unstructured":"Ross JW, Whyte JJ, Zhao J, Samuel M, Wells KD, Prather RS (2010) Optimization of square-wave electroporation for transfection of porcine fetal fibroblasts. Transgenic Res 19:611\u2013620","journal-title":"Transgenic Res"},{"key":"9496_CR40","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","volume":"94","author":"B Schrank","year":"1997","unstructured":"Schrank B, Gotz R, Gunnersen JM, Ure JM, Toyka KV, Smith AG, Sendtner M (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci USA 94:9920\u20139925","journal-title":"Proc Natl Acad Sci USA"},{"key":"9496_CR41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4161\/rna.6.3.8723","volume":"6","author":"NN Singh","year":"2009","unstructured":"Singh NN, Shishimorova M, Cao LC, Gangwani L, Singh RN (2009) A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy. RNA Biol 6:341\u2013350","journal-title":"RNA Biol"},{"key":"9496_CR42","first-page":"3","volume":"3","author":"M Stavarachi","year":"2010","unstructured":"Stavarachi M, Apostol P, Toma M, Cimponeriu D, Gavrila L (2010) Spinal muscular atrophy disease: a literature review for therapeutic strategies. J Med Life 3:3\u20139","journal-title":"J Med Life"},{"key":"9496_CR43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"CJ Sumner","year":"2003","unstructured":"Sumner CJ, Huynh TN, Markowitz JA, Perhac JS, Hill B, Coovert DD, Schussler K, Chen X, Jarecki J, Burghes AH et al (2003) Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 54:647\u2013654","journal-title":"Ann Neurol"},{"key":"9496_CR44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/jm061475p","volume":"51","author":"J Thurmond","year":"2008","unstructured":"Thurmond J, Butchbach ME, Palomo M, Pease B, Rao M, Bedell L, Keyvan M, Pai G, Mishra R, Haraldsson M et al (2008) Synthesis and biological evaluation of novel 2, 4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. J Med Chem 51:449\u2013469","journal-title":"J Med Chem"},{"key":"9496_CR45","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","volume":"2","author":"CF Valori","year":"2010","unstructured":"Valori CF, Ning K, Wyles M, Mead RJ, Grierson AJ, Shaw PJ, Azzouz M (2010) Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci Transl Med 2:35ra42","journal-title":"Sci Transl Med"},{"key":"9496_CR46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B (2000) An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 15:228\u2013237","journal-title":"Hum Mutat"},{"key":"9496_CR47","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddi131","volume":"14","author":"EC Wolstencroft","year":"2005","unstructured":"Wolstencroft EC, Mattis V, Bajer AA, Young PJ, Lorson CL (2005) A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels. Hum Mol Genet 14:1199\u20131210","journal-title":"Hum Mol Genet"},{"key":"9496_CR48","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.gt.3301550","volume":"8","author":"ML Zhang","year":"2001","unstructured":"Zhang ML, Lorson CL, Androphy EJ, Zhou J (2001) An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Ther 8:1532\u20131538","journal-title":"Gene Ther"},{"key":"9496_CR49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1095\/biolreprod.109.077016","volume":"81","author":"J Zhao","year":"2009","unstructured":"Zhao J, Ross JW, Hao Y, Spate LD, Walters EM, Samuel MS, Rieke A, Murphy CN, Prather RS (2009) Significant improvement in cloning efficiency of an inbred miniature pig by histone deacetylase inhibitor treatment after somatic cell nuclear transfer. Biol Reprod 81:525\u2013530","journal-title":"Biol Reprod"}],"container-title":["Transgenic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11248-011-9496-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11248-011-9496-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11248-011-9496-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:29:23Z","timestamp":1559374163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11248-011-9496-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,25]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9496"],"URL":"https:\/\/doi.org\/10.1007\/s11248-011-9496-8","relation":{},"ISSN":["0962-8819","1573-9368"],"issn-type":[{"value":"0962-8819","type":"print"},{"value":"1573-9368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,25]]}}}